Setipafant 是一種血小板活化因子 (<b>PAF</b>) 拮抗劑。<BR><a href="https://www.medchemexpress.cn/Nutlin-3a.html">Nutlin (3a)</a>產(chǎn)品描述:Nutlin (3a) is a murine double minute (<b>MDM2</b>) antagonist that inhibits <b>MDM2-p53</b> interactions and stabilizes the p53 protein, thereby inducing cell cycle arrest and apoptosis.IC50 & Target: MDM2-p53<sup>[1]</sup><i><b>In Vitro:</b></i> Nutlin-3a is a therapeutic which inhibits MDM2, activates wild-type p53, and induces apoptosis-as a therapeutic compound for <i>TP53</i> wild-type ovarian carcinomas. Three cell lines (HOC-7, OVCA429 and A2780) with wild-type <i>TP53</i> are highly sensitive to Nutlin-3a (IC<sub>50</sub>=4 to 6 μM). SKOV3 cells have an IC<sub>50</sub> of 38 μM to Nutlin-3a. The two remaining ovarian clear cell lines (TOV21G and OVAS), both with <i>TP53</i> wild-type, are relatively more sensitive to growth inhibition with Nutlin-3a (IC<sub>50</sub>=14 and 25 μm respectively) than the <i>TP53</i> mutant cell lines<sup>[1]</sup>. Nutlin-3a is the active enantiomer of Nutlin-3. Nutlin-3a is a highly selective MDM2 antagonist and p53 inducer. Seven days of<br><br><br><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">公司介紹:MedChemExpress(MCE)專注于各種抑制劑、激動劑、API及化合物庫,總部位于美國新澤西,分別在瑞典和上海設(shè)有歐洲區(qū)子公司和亞洲區(qū)總代理,營銷網(wǎng)點遍及全球20多個國家地區(qū)。MCE經(jīng)過多年努力已成為全球生物活性小分子領(lǐng)域的一流供應商, 產(chǎn)品涵蓋癌癥、神經(jīng)科學、抗感染、表觀遺傳學等20個熱門研究領(lǐng)域,PI3K、MAPK等近千個細分靶點,超過4000個活性小分子化合物現(xiàn)貨,以及GPCR、API、離子通道等超過20種不同類型的化合物庫,同時提供從毫克到千克的專業(yè)定制合成服務。</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">MCE 對每批產(chǎn)品都進行嚴格的LCMS和NMR檢驗,其產(chǎn)品已被全球近萬名客戶廣泛使用并發(fā)表大量文章、專利;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">MCE 定期增加各領(lǐng)域熱門抑制劑、激動劑,不斷擴增已有化合物庫,以滿足最新的科研需求;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">數(shù)千種產(chǎn)品在上海有充足備貨,24-48小時內(nèi)送達客戶;</span><br style="color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;line-height: 22.0px;background-color: rgb(251,251,251);"><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">大量產(chǎn)品提供免費試用裝;</span><span style="outline: 0.0px;line-height: 22.0px;color: rgb(62,62,62);font-family: "Helvetica Neue" , Helvetica , Arial , sans-serif;font-size: 11.818182px;background-color: rgb(251,251,251);">已為全球多個知名企業(yè)、院校構(gòu)建各種定制型化合物庫。</span><br><br>產(chǎn)品鏈接:<a href="http://www.medchemexpress.cn/Nutlin-3a.html">www.medchemexpress.cn/Nutlin-3a.html</a><br><br></span><img style="width: 600.0px;height: 310.0px;" src="http://img.dxycdn.com/trademd/upload/userfiles/image/2014/08/A1408605159png_small.jpg" alt="">Purity:98%<BR>MWt:519.0178<BR>Formula:C26H23ClN6O2S<BR>SMILES:O=C(N(C1)CCC2=C1SC3=C2C(C4=CC=CC=C4Cl)=NCC5=NN=C(C)N53)NC6=CC=C(OC)C=C6<BR>Pathway:Others; <BR>Mechanisms:Others; <BR>Research Area:Cardiovascular Disease<BR>電話: 021-58955995<BR>網(wǎng)址: www.MedChemExpress.cn <BR>地址: 上海市浦東新區(qū)蔡倫路720號2號樓3層 |
Setipafant前沿研究進展
發(fā)布日期:2017-11-13 瀏覽次數(shù):0
核心提示:Setipafant 是一種血小板活化因子 (bPAF/b) 拮抗劑。BRa href=https://www.medchemexpress.cn/Nutlin-3a.htmlNutlin (3a)/a產(chǎn)品
- 下一篇:暫無
- 上一篇:Tiapamil (hydrochloride)前沿研究進展
行業(yè)動態(tài)
更多...
- Setipafant前沿研究進展 11-13
- Tiapamil (hydrochloride) 11-13
- MTPPA前沿研究進展 11-13
- TDN345前沿研究進展 11-13
- Sulamserod前沿研究進展 11-13
- Win 58237前沿研究進展 11-13
- Nifursemizone前沿研究進 11-13
- Pargolol (hydrochloride) 11-13
- COX2-IN-1前沿研究進展 11-13
- MHP 133前沿研究進展 11-13